Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion type Assertion NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_head.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion description "[The ANXA10 protein was expressed in 43.5% (155 cases) of gastric carcinomas; 74.2% (98/132) in the diffuse-type gastric carcinoma (DGC), 73.7% (28/38) in the mixed-type gastric carcinoma, and significantly lower in the intestinal-type gastric carcinoma (IGC) and indeterminate groups, 16.8% (28/167) and 5.3% (1/19), respectively (P<1�10(-8)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_provenance.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion evidence source_evidence_literature NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_provenance.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion SIO_000772 21175800 NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_provenance.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion wasDerivedFrom befree-20140225 NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_provenance.
- NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_assertion wasGeneratedBy ECO_0000203 NP508006.RA_CiNlUig2Gdz5pATG81Ja6V3fqb6jvXEy2LxlwcwsqI130_provenance.